-
1
-
-
0022540321
-
CpG-rich islands and the function of DNA methylation
-
Bird AP. 1986. CpG-rich islands and the function of DNA methylation. Nature 321: 209- 213.
-
(1986)
Nature
, vol.321
, pp. 209-213
-
-
Bird, A.P.1
-
2
-
-
15444368857
-
Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes
-
Bjornstrom L, Sjoberg M. 2005. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19: 833- 842.
-
(2005)
Mol Endocrinol
, vol.19
, pp. 833-842
-
-
Bjornstrom, L.1
Sjoberg, M.2
-
3
-
-
0141885036
-
Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation
-
Bouchain G, Delorme D. 2003. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation. Curr Med Chem 10: 2359- 2372.
-
(2003)
Curr Med Chem
, vol.10
, pp. 2359-2372
-
-
Bouchain, G.1
Delorme, D.2
-
4
-
-
0037468554
-
Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors
-
Bouchain G, Leit S, Frechette S, Khalil EA, Lavoie R, Moradei O, Woo SH, Fournel M, Yan PT, Kalita A, Trachy-Bourget MC, Beaulieu C, Li Z, Robert MF, MacLeod AR, Besterman JM, Delorme D. 2003. Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors. J Med Chem 46: 820- 830.
-
(2003)
J Med Chem
, vol.46
, pp. 820-830
-
-
Bouchain, G.1
Leit, S.2
Frechette, S.3
Khalil, E.A.4
Lavoie, R.5
Moradei, O.6
Woo, S.H.7
Fournel, M.8
Yan, P.T.9
Kalita, A.10
Trachy-Bourget, M.C.11
Beaulieu, C.12
Li, Z.13
Robert, M.F.14
MacLeod, A.R.15
Besterman, J.M.16
Delorme, D.17
-
6
-
-
32944482243
-
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
-
Cui X, Schiff R, Arpino G, Osborne CK, Lee AV. 2005. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol 23: 7721- 7735.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7721-7735
-
-
Cui, X.1
Schiff, R.2
Arpino, G.3
Osborne, C.K.4
Lee, A.V.5
-
7
-
-
0032490874
-
Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression
-
Ferguson AT, Lapidus RG, Davidson NE. 1998. Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression. Oncogene 17: 577- 583.
-
(1998)
Oncogene
, vol.17
, pp. 577-583
-
-
Ferguson, A.T.1
Lapidus, R.G.2
Davidson, N.E.3
-
8
-
-
82155188552
-
The tumor suppressor role of CTCF
-
DOI: 10.1002/jcp.22780.
-
Fiorentino FP, Giordano A. 2012. The tumor suppressor role of CTCF. J Cell Physiol 227: 479- 492. DOI: 10.1002/jcp.22780.
-
(2012)
J Cell Physiol
, vol.227
, pp. 479-492
-
-
Fiorentino, F.P.1
Giordano, A.2
-
9
-
-
31444449552
-
Epigenetic information and estrogen receptor alpha expression in breast cancer
-
Giacinti L, Claudio PP, Lopez M, Giordano A. 2006. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11: 1- 8.
-
(2006)
Oncologist
, vol.11
, pp. 1-8
-
-
Giacinti, L.1
Claudio, P.P.2
Lopez, M.3
Giordano, A.4
-
11
-
-
0035834786
-
Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C
-
Han JW, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S, Lee HY, Lee YW, Lee HW. 2001. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C. J Biol Chem 276: 42084- 42090.
-
(2001)
J Biol Chem
, vol.276
, pp. 42084-42090
-
-
Han, J.W.1
Ahn, S.H.2
Kim, Y.K.3
Bae, G.U.4
Yoon, J.W.5
Hong, S.6
Lee, H.Y.7
Lee, Y.W.8
Lee, H.W.9
-
12
-
-
0034326799
-
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin
-
Han JW, Ahn SH, Park SH, Wang SY, Bae GU, Seo DW, Kwon HK, Hong S, Lee HY, Lee YW, Lee HW. 2000. Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolin. Cancer Res 60: 6068- 6074.
-
(2000)
Cancer Res
, vol.60
, pp. 6068-6074
-
-
Han, J.W.1
Ahn, S.H.2
Park, S.H.3
Wang, S.Y.4
Bae, G.U.5
Seo, D.W.6
Kwon, H.K.7
Hong, S.8
Lee, H.Y.9
Lee, Y.W.10
Lee, H.W.11
-
13
-
-
1842422439
-
Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer
-
Hanstein B, Djahansouzi S, Dall P, Beckmann MW, Bender HG. 2004. Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol 150: 243- 255.
-
(2004)
Eur J Endocrinol
, vol.150
, pp. 243-255
-
-
Hanstein, B.1
Djahansouzi, S.2
Dall, P.3
Beckmann, M.W.4
Bender, H.G.5
-
14
-
-
13944274571
-
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding
-
Hu J, Colburn NH. 2005. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res 3: 100- 109.
-
(2005)
Mol Cancer Res
, vol.3
, pp. 100-109
-
-
Hu, J.1
Colburn, N.H.2
-
15
-
-
0242335773
-
Molecular action of the estrogen receptor and hormone dependency in breast cancer
-
Iwase H. 2003. Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 10: 89- 96.
-
(2003)
Breast Cancer
, vol.10
, pp. 89-96
-
-
Iwase, H.1
-
16
-
-
0028886694
-
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
-
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270: 1491- 1494.
-
(1995)
Science
, vol.270
, pp. 1491-1494
-
-
Kato, S.1
Endoh, H.2
Masuhiro, Y.3
Kitamoto, T.4
Uchiyama, S.5
Sasaki, H.6
Masushige, S.7
Gotoh, Y.8
Nishida, E.9
Kawashima, H.10
Metzger, D.11
Chambon, P.12
-
17
-
-
0142122363
-
Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha
-
Kawai H, Li H, Avraham S, Jiang S, Avraham HK. 2003. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int J Cancer 107: 353- 358.
-
(2003)
Int J Cancer
, vol.107
, pp. 353-358
-
-
Kawai, H.1
Li, H.2
Avraham, S.3
Jiang, S.4
Avraham, H.K.5
-
18
-
-
0242330341
-
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine
-
Keen JC, Yan L, Mack KM, Pettit C, Smith D, Sharma D, Davidson NE. 2003. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast Cancer Res Treat 81: 177- 186.
-
(2003)
Breast Cancer Res Treat
, vol.81
, pp. 177-186
-
-
Keen, J.C.1
Yan, L.2
Mack, K.M.3
Pettit, C.4
Smith, D.5
Sharma, D.6
Davidson, N.E.7
-
19
-
-
0032526094
-
Mapping of ER gene CpG island methylation-specific polymerase chain reaction
-
Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE. 1998a. Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 58: 2515- 2519.
-
(1998)
Cancer Res
, vol.58
, pp. 2515-2519
-
-
Lapidus, R.G.1
Nass, S.J.2
Butash, K.A.3
Parl, F.F.4
Weitzman, S.A.5
Graff, J.G.6
Herman, J.G.7
Davidson, N.E.8
-
20
-
-
0031597992
-
The loss of estrogen and progesterone receptor gene expression in human breast cancer
-
Lapidus RG, Nass SJ, Davidson NE. 1998b. The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3: 85- 94.
-
(1998)
J Mammary Gland Biol Neoplasia
, vol.3
, pp. 85-94
-
-
Lapidus, R.G.1
Nass, S.J.2
Davidson, N.E.3
-
21
-
-
85077951985
-
The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
-
Marks PA. 2004. The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA). Cell Cycle 3: 534- 535.
-
(2004)
Cell Cycle
, vol.3
, pp. 534-535
-
-
Marks, P.A.1
-
22
-
-
2942724589
-
Histone deacetylase inhibitors: Development as cancer therapy
-
discussion 281-288.
-
Marks PA, Richon VM, Kelly WK, Chiao JH, Miller T. 2004. Histone deacetylase inhibitors: Development as cancer therapy. Novartis Found Symp 259: 269- 281; discussion 281-288.
-
(2004)
Novartis Found Symp
, vol.259
, pp. 269-281
-
-
Marks, P.A.1
Richon, V.M.2
Kelly, W.K.3
Chiao, J.H.4
Miller, T.5
-
23
-
-
0037204724
-
Connections and regulation of the human estrogen receptor
-
McDonnell DP, Norris JD. 2002. Connections and regulation of the human estrogen receptor. Science 296: 1642- 1644.
-
(2002)
Science
, vol.296
, pp. 1642-1644
-
-
McDonnell, D.P.1
Norris, J.D.2
-
24
-
-
0037462733
-
Proximal events in signaling by plasma membrane estrogen receptors
-
Razandi M, Pedram A, Park ST, Levin ER. 2003. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278: 2701- 2712.
-
(2003)
J Biol Chem
, vol.278
, pp. 2701-2712
-
-
Razandi, M.1
Pedram, A.2
Park, S.T.3
Levin, E.R.4
-
25
-
-
0038079767
-
The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1
-
Rosato RR, Almenara JA, Grant S. 2003. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res 63: 3637- 3645.
-
(2003)
Cancer Res
, vol.63
, pp. 3637-3645
-
-
Rosato, R.R.1
Almenara, J.A.2
Grant, S.3
-
26
-
-
0033520944
-
Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects
-
Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, Trogani N, Xu H, Cohen D. 1999. Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274: 34940- 34947.
-
(1999)
J Biol Chem
, vol.274
, pp. 34940-34947
-
-
Sambucetti, L.C.1
Fischer, D.D.2
Zabludoff, S.3
Kwon, P.O.4
Chamberlin, H.5
Trogani, N.6
Xu, H.7
Cohen, D.8
-
27
-
-
25844509783
-
Steroid hormone receptor signaling in tumorigenesis
-
Singh RR, Kumar R. 2005. Steroid hormone receptor signaling in tumorigenesis. J Cell Biochem 96: 490- 505.
-
(2005)
J Cell Biochem
, vol.96
, pp. 490-505
-
-
Singh, R.R.1
Kumar, R.2
-
28
-
-
0034124166
-
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library
-
Su GH, Sohn TA, Ryu B, Kern SE. 2000. A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. Cancer Res 60: 3137- 3142.
-
(2000)
Cancer Res
, vol.60
, pp. 3137-3142
-
-
Su, G.H.1
Sohn, T.A.2
Ryu, B.3
Kern, S.E.4
-
29
-
-
33644863529
-
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells
-
Takai N, Ueda T, Nishida M, Nasu K, Narahara H. 2006. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. Int J Mol Med 17: 323- 329.
-
(2006)
Int J Mol Med
, vol.17
, pp. 323-329
-
-
Takai, N.1
Ueda, T.2
Nishida, M.3
Nasu, K.4
Narahara, H.5
-
30
-
-
0036176617
-
Histone deacetylase inhibitors in cancer treatment
-
Vigushin DM, Coombes RC. 2002. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13: 1- 13.
-
(2002)
Anticancer Drugs
, vol.13
, pp. 1-13
-
-
Vigushin, D.M.1
Coombes, R.C.2
-
32
-
-
0027295315
-
Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma
-
Weigel RJ, deConinck EC. 1993. Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma. Cancer Res 53: 3472- 3474.
-
(1993)
Cancer Res
, vol.53
, pp. 3472-3474
-
-
Weigel, R.J.1
deConinck, E.C.2
-
33
-
-
1542787625
-
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines
-
Yan L, Nass SJ, Smith D, Nelson WG, Herman JG, Davidson NE. 2003. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Ther 2: 552- 556.
-
(2003)
Cancer Biol Ther
, vol.2
, pp. 552-556
-
-
Yan, L.1
Nass, S.J.2
Smith, D.3
Nelson, W.G.4
Herman, J.G.5
Davidson, N.E.6
-
34
-
-
0034671304
-
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition
-
Yang X, Ferguson AT, Nass SJ, Phillips DL, Butash KA, Wang SM, Herman JG, Davidson NE. 2000. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. Cancer Res 60: 6890- 6894.
-
(2000)
Cancer Res
, vol.60
, pp. 6890-6894
-
-
Yang, X.1
Ferguson, A.T.2
Nass, S.J.3
Phillips, D.L.4
Butash, K.A.5
Wang, S.M.6
Herman, J.G.7
Davidson, N.E.8
-
35
-
-
0035477320
-
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells
-
Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE. 2001. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. Cancer Res 61: 7025- 7029.
-
(2001)
Cancer Res
, vol.61
, pp. 7025-7029
-
-
Yang, X.1
Phillips, D.L.2
Ferguson, A.T.3
Nelson, W.G.4
Herman, J.G.5
Davidson, N.E.6
-
36
-
-
0034522739
-
Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors
-
Yoshida T, Eguchi H, Nakachi K, Tanimoto K, Higashi Y, Suemasu K, Iino Y, Morishita Y, Hayashi S. 2000. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors. Carcinogenesis 21: 2193- 2201.
-
(2000)
Carcinogenesis
, vol.21
, pp. 2193-2201
-
-
Yoshida, T.1
Eguchi, H.2
Nakachi, K.3
Tanimoto, K.4
Higashi, Y.5
Suemasu, K.6
Iino, Y.7
Morishita, Y.8
Hayashi, S.9
|